With Promise of Legalization, Psychedelic Companies Joust Over Future Profits

Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.

Source: NYT Health - October 25, 2022 Category: Consumer Health News Authors: Andrew Jacobs Tags: Inventions and Patents Psychedelic and Hallucinogenic Drugs Mental Health and Disorders Research Drugs (Pharmaceuticals) Depression (Mental) Intellectual Property Source Type: news